» Journals » Curr Opin Endocrinol Diabetes Obes

Current Opinion in Endocrinology, Diabetes, and Obesity

Current Opinion in Endocrinology, Diabetes, and Obesity is a reputable journal that provides concise and up-to-date reviews on the latest advancements in the field of endocrinology, diabetes, and obesity. It offers expert opinions and critical evaluations of recent research, helping clinicians, researchers, and healthcare professionals stay informed about emerging trends, diagnostic tools, therapeutic approaches, and management strategies in these interconnected areas.

Details
Abbr. Curr Opin Endocrinol Diabetes Obes
Start 2007
End Continuing
Frequency Bimonthly
p-ISSN 1752-296X
e-ISSN 1752-2978
Country United Kingdom
Language English
Specialty Endocrinology
Metrics
h-index / Ranks: 4133 83
SJR / Ranks: 4073 959
CiteScore / Ranks: 5214 4.90
JIF / Ranks: 3189 3.2
Recent Articles
1.
Weijs B, Oostveen R, Kraaijenhof J, Stroes E
Curr Opin Endocrinol Diabetes Obes . 2025 Feb; PMID: 40012530
Purpose Of Review: The aim of this review is to examine recent advancements in RNA-targeted therapies for the management of severe hypertriglyceridemia (sHTG) and prevention of sHTG-associated acute pancreatitis. Recent...
2.
Curr Opin Endocrinol Diabetes Obes . 2025 Feb; 32(2):v. PMID: 39998629
No abstract available.
3.
Yu R, Weber H
Curr Opin Endocrinol Diabetes Obes . 2025 Feb; PMID: 39968682
Purpose Of Review: To provide an update of recent studies exploring the role of the gut microbiota and diet in the pathogenesis and treatment of irritable bowel syndrome (IBS). Recent...
4.
Burvill A, Watts G, Ademi Z
Curr Opin Endocrinol Diabetes Obes . 2025 Feb; 32(2):89-95. PMID: 39936471
Purpose Of Review: Early health economic evaluations of new medications are useful, as they consider the implications for health services.We reviewed recent literature on expected clinical outcomes of lowering of...
5.
Larouche M, Watts G, Ballantyne C, Gaudet D
Curr Opin Endocrinol Diabetes Obes . 2025 Feb; 32(2):75-88. PMID: 39927417
Purpose Of Review: The aim of this review is to provide an overview of severe hypertriglyceridemia presenting in the form of chylomicronemia that persists despite treatment of secondary causes and...
6.
Hagger M, Hamilton K
Curr Opin Endocrinol Diabetes Obes . 2025 Jan; 32(2):52-58. PMID: 39773818
Purpose Of Review: Patients with familial hypercholesterolemia have an elevated risk of premature atherosclerotic cardiovascular disease. Risks can be minimized through pharmacological and 'lifestyle' behavioral (low fat diet, physical activity)...
7.
Rigas G, Alexander S, Haywood C
Curr Opin Endocrinol Diabetes Obes . 2024 Dec; 32(1):26-33. PMID: 39692102
Purpose Of Review: Obesity is recognized as a "gateway" chronic, progressive disease of dysfunctional adipocytes. Glucagon-like peptide-1 receptor agonist-based therapies (GLP1BTs), including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with/without glucose-dependent...
8.
Loh W
Curr Opin Endocrinol Diabetes Obes . 2024 Dec; 32(1):3-11. PMID: 39692101
Purpose Of Review: The aim of this review was to discuss the use and concerns of diabetes agents, clinical targets, and key aspects to be considered in the management of...
9.
Loh W
Curr Opin Endocrinol Diabetes Obes . 2024 Dec; 32(1):1-2. PMID: 39692100
No abstract available.
10.
Curr Opin Endocrinol Diabetes Obes . 2024 Dec; 32(1):v. PMID: 39692099
No abstract available.